Oncology Clinics in India: 2026 B2B Database & Market Analysis

Overview

In 2026, India's oncology landscape is undergoing a massive transformation driven by localized, specialized cancer care centers. The traditional model of relying solely on massive government hospitals like the Tata Memorial Hospital in Mumbai or AIIMS in New Delhi is shifting. Today, private standalone oncology clinics and specialized day-care chemotherapy centers are popping up rapidly across Tier-1 and Tier-2 cities to address the rising burden of cancer, which is projected to reach over 1.5 million cases annually in the country according to ICMR data. These specialized clinics offer localized, high-quality care, reducing travel times for patients who previously had to journey thousands of kilometers for treatment.

For global pharmaceutical enterprises, domestic medical device manufacturers like those based in the Andhra Pradesh MedTech Zone (AMTZ), and digital health startups, accessing this highly fragmented market is a major challenge. Accurate, verified B2B data is the critical bridge needed to reach decision-makers in this sector. Whether you are selling advanced radiotherapy planning software, specialized infusion pumps, or offering localized clinical trial recruitment services, having direct access to the clinical directors, purchasing managers, and chief oncologists at these facilities is essential to unlocking growth within India’s complex, multi-layered healthcare ecosystem.

This comprehensive guide provides an in-depth analysis of the oncology clinic market in India as of 2026. We explore the structural shifts happening across regional healthcare hubs, detail the specific data attributes available in our premium B2B database, and outline how commercial teams are leveraging this intelligence to drive sales. You will gain a clear understanding of the regulatory environment, regional clinic density, and the exact methodology used to ensure our database remains the most accurate and actionable resource for B2B sales professionals targeting the Indian oncology market.

State of Oncology Clinics in India (2026)

The oncology clinics market in India is expanding at an unprecedented compound annual growth rate, fueled by substantial private equity investments and the expansion of specialized chains. Major players like HCG (Healthcare Global Enterprises), headquartered in Bengaluru, and Apollo Cancer Centres, which operates across Chennai, Hyderabad, and Kolkata, are leading the charge by establishing smaller, decentralized day-care oncology clinics. These decentralized hubs focus on delivering outpatient chemotherapy, immunotherapy, and targeted consultations, allowing patients to bypass the crowded wards of multi-specialty corporate hospitals. Additionally, regional players such as Cancer Clinics India in Telangana and suburban Delhi-NCR are rapidly scaling their physical footprints.

This expansion is also heavily influenced by government initiatives and regulatory shifts. The National Health Authority (NHA) has integrated complex oncology packages into the Ayushman Bharat PM-JAY scheme, incentivizing private oncology clinics to standardize their pricing and scale their services to semi-urban populations. Furthermore, the Central Drugs Standard Control Organisation (CDSCO) has streamlined the approval process for cancer drugs and medical devices, encouraging clinics in medical hubs like Pune, Ahmedabad, and Kochi to adopt state-of-the-art diagnostic equipment and cutting-edge targeted therapies much faster than in previous decades.

Geographically, the distribution of these clinics is highly concentrated but expanding. South India, particularly Chennai and Bengaluru, remains a dominant hub due to its robust medical tourism infrastructure and a high density of qualified surgical and medical oncologists. Meanwhile, West India, anchored by Mumbai and Pune, is seeing a surge in high-tech stereotactic radiosurgery clinics. In the North, the Delhi National Capital Region (including Gurugram and Noida) acts as a primary magnet for patients from neighboring states like Uttar Pradesh and Haryana, driving a massive demand for localized, high-throughput private oncology clinics.

What's in the India dataset

Our B2B database of oncology clinics in India is meticulously curated to provide unmatched depth and accuracy. Each profile includes essential institutional identifiers such as the registered clinical name, state-issued clinical establishment license numbers, and Goods and Services Tax Identification Numbers (GSTIN) where applicable. We capture the exact geographic coordinates (GPS latitude and longitude) for every facility, enabling field sales teams representing surgical instrument manufacturers or laboratory service providers to plan highly efficient regional sales routes across sprawling metros like Mumbai or Hyderabad.

Beyond institutional data, our database prioritizes direct, human-verified contact channels. We provide direct mobile numbers—which are the primary communication channel in India's business landscape—alongside verified corporate email addresses of key decision-makers, including Chief Medical Directors, Lead Oncologists, and Procurement Officers. To facilitate multi-channel digital marketing campaigns, we map the active social media handles of these clinics, particularly their LinkedIn profiles and WhatsApp Business numbers, which have become vital for professional B2B outreach and relationship building across the Indian medical community.

Data integrity is maintained through a rigorous, multi-step verification process tailored to the Indian market. Our local research team combines automated web scraping of state clinical registries with manual phone verification conducted by native-speaking agents who understand regional healthcare nuances. The database undergoes a comprehensive refresh cycle every 90 days to account for new clinic openings, relocations, and personnel shifts, ensuring that your sales and marketing teams never waste valuable time or resources on outdated, bounced, or inaccurate lead information.

Top Oncology Clinics hubs in India

Coverage breakdown by city, sorted by verified record count.

Who buys Oncology Clinics India data

This premium dataset is primarily utilized by sales and marketing leaders at multinational pharmaceutical companies (such as those with offices in Mumbai's Bandra-Kurla Complex) looking to promote next-generation biosimilars, immunotherapy drugs, and supportive care therapeutics directly to prescribing oncologists. With the rise of localized day-care chemotherapy, having direct access to independent clinic owners allows pharma reps to bypass complex hospital formulary committees and secure faster clinical adoption of their specialized therapeutic portfolios.

Additionally, medical device manufacturers specializing in radiation oncology, chemotherapy compounding systems, and diagnostic imaging equipment rely heavily on this data. Sales managers at companies manufacturing medical hardware in hubs like Chennai or the Delhi NCR use our database to identify and target newly established private clinics that are actively expanding their diagnostic and treatment capabilities. Having verified contact details of the purchasing decision-makers allows these teams to shorten their B2B sales cycles significantly.

Lastly, diagnostic laboratory chains, clinical research organizations (CROs) conducting oncology trials in India, and digital health software providers (offering Electronic Medical Records tailored for oncology) find immense value in our database. By targeting specific, high-growth clinics in cities like Bengaluru, Ahmedabad, and Pune, these B2B players can pitch localized partnership opportunities, diagnostic outsourcing contracts, or specialized cloud-based clinic management software directly to the administrative heads of these fast-growing oncology facilities.

Pricing for Oncology Clinics in India

We offer a highly flexible, transparent pricing structure designed to accommodate the varying budgets of growing Indian startups and established multinational enterprises alike. Our database is available on a per-record pricing model with no hidden fees or long-term contract requirements, allowing you to pay only for the specific geographic regions or clinic sizes you need. Alternatively, we offer pay-as-you-go credits that can be used to download targeted segments of the database as your regional expansion plans unfold across different states.

All purchases include a comprehensive commercial usage license, granting your organization the right to integrate the data into your local CRM systems (such as Salesforce or Zoho CRM) for direct sales outreach, email marketing campaigns, and tele-calling initiatives. The data is delivered in standard, easily importable formats such as CSV or Excel, ensuring your sales development representatives in Delhi, Mumbai, or Bengaluru can begin their outreach campaigns immediately without any technical bottlenecks.

Frequently asked questions

As India's oncology sector continues to decentralize and expand rapidly through 2026, staying ahead of your competitors requires precise, reliable, and up-to-date market intelligence. Relying on outdated directories or generic databases will only lead to wasted marketing spend and missed sales opportunities in this highly specialized medical field. Take the strategic step to empower your sales and marketing teams with the most accurate oncology clinic database in India. Contact our team today to request a free sample dataset tailored to your target cities and discover how we can help you accelerate your B2B sales growth.